Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus.
Yang JJ, Goff A, Wild DJ, Ding Y, Annis A, Kerber R, Foote B, Passi A, Duerksen JL, London S, Puhl AC, Lane TR, Braunstein M, Waddell SJ, Ekins S. Yang JJ, et al. Among authors: annis a. Tuberculosis (Edinb). 2024 May;146:102500. doi: 10.1016/j.tube.2024.102500. Epub 2024 Feb 27. Tuberculosis (Edinb). 2024. PMID: 38432118 Free article.
The phenotype-genotype reference map: Improving biobank data science through replication.
Bastarache L, Delozier S, Pandit A, He J, Lewis A, Annis AC, LeFaive J, Denny JC, Carroll RJ, Altman RB, Hughey JJ, Zawistowski M, Peterson JF. Bastarache L, et al. Among authors: annis ac. Am J Hum Genet. 2023 Sep 7;110(9):1522-1533. doi: 10.1016/j.ajhg.2023.07.012. Epub 2023 Aug 21. Am J Hum Genet. 2023. PMID: 37607538 Free PMC article.
Pharmacokinetic Considerations for Optimizing Inhaled Spray-Dried Pyrazinoic Acid Formulations.
Yeshwante SB, Hanafin P, Miller BK, Rank L, Murcia S, Xander C, Annis A, Baxter VK, Anderson EJ, Jermain B, Konicki R, Schmalstig AA, Stewart I, Braunstein M, Hickey AJ, Rao GG. Yeshwante SB, et al. Among authors: annis a. Mol Pharm. 2023 Sep 4;20(9):4491-4504. doi: 10.1021/acs.molpharmaceut.3c00199. Epub 2023 Aug 17. Mol Pharm. 2023. PMID: 37590399
Pharmacokinetic considerations for optimizing inhaled spray-dried pyrazinoic acid formulations.
Yeshwante SB, Hanafin P, Miller BK, Rank L, Murcia S, Xander C, Annis A, Baxter VK, Anderson EJ, Jermain B, Konicki R, Schmalstig AA, Stewart I, Braunstein M, Hickey AJ, Rao GG. Yeshwante SB, et al. Among authors: annis a. bioRxiv [Preprint]. 2023 Apr 3:2023.04.01.534965. doi: 10.1101/2023.04.01.534965. bioRxiv. 2023. PMID: 37066292 Free PMC article. Updated. Preprint.
47 results